LIGAND PHARMACEUTICALS
LGND·53220K504·US·Common Stock·Healthcare - Biotechnology-13D/G
LGND (LIGAND PHARMACEUTICALS) is held by 174 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($980.2M), Invesco Ltd. ($379.8M), VANGUARD PORTFOLIO MANAGEMENT LLC ($359.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 108 funds bought LGND.
174
Holders
(15 Elite)
$5.5B
Total Value
60% (180)
Consensus
108 buying - 72 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 14, 2026 · Activists Aug 13, 2026 · Congress Jun 8, 2026
InsiderEOEspinoza OctavioExercise 2K shAug 12, 2026
InsiderEOEspinoza OctavioExercise 3K shAug 12, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 188
1 / 10
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer